Business
Why the Neuren (ASX:NEU) share price is moving higher today
Neuren Pharmaceuticals Ltd (ASX: NEU) shares are trending higher in early afternoon trade. This comes after the biotech company announced it has successfully completed manufacturing a drug substance for its Phase 2 trials.
At the time of writing, the Neuren share price has jumped to an intraday high of $1.28, up 1.99% for the day so far.
What did Neuren announce?
The Neuren share price is edging higher as investors appear pleased with the company’s progress.
According to its release, Neuren’s second drug candidate, NNZ-2591, has been manufactured ahead of Phase 2 trials. The company is currently preparing to submit Investigational New Drug…
-
Noosa News20 hours agoWoman dead and man rushed to hospital with gunshot wound following crash near Aussie World on Queensland’s Sunshine Coast
-
Noosa News20 hours agoBrisbane-bound traffic diverted after pile-ups along Bruce Highway
-
Noosa News20 hours agoMan arrested after police chase: Driver shot, woman dies in crash
-
General15 hours agoAustralian Catholics mourning death of Pope Francis